Recent health news and videos.
Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.
Researchers in Boston are working on an ingestible alternative to daily oral contraceptive pills.
Older adults who use aspirin this many times per week may lower their risk of dying of cancer.
Women taking birth control pills may experience changes in a key region of the brain.
SATURDAY, Dec. 7, 2019 (HealthDay News) -- Prescription-grade CBD may help control hard-to-treat seizures caused by a rare genetic disorder, a preliminary study suggests.
The study involved 224 patients with tuberous sclerosis complex (TSC) -- a genetic condition that affects about one in 6,000 people, according to the U.S. National In...
SATURDAY, Dec. 7, 2019 (HealthDay News) -- If you can tackle a tough workout, that may bode well for your longevity, new research suggests.
A woman's risk of dying from heart disease, cancer or other causes is much lower if she can engage in vigorous exercise, scientists report.
The new study included more than 4,700 middle-a...
FRIDAY, Dec. 6, 2019 (HealthDay News) -- A healthy lifestyle might be your best defense against cancer, an expert says.
About 42% of cancer cases and 45% of cancer deaths are attributable to modifiable risk factors, according to the American Cancer Society.
"Modifiable risk factors are behaviors within one's control, ...
FRIDAY, Dec. 6, 2019 (HealthDay News) -- If you have a neurological disorder, a video chat with your doctor might be as good as an office visit for checking on your condition.
That's the conclusion of researchers who analyzed 101 studies on telemedicine use for concussion, traumatic brain injury, dementia, epilepsy, headache, multiple ...
FRIDAY, Dec. 6, 2019 (HealthDay News) -- Levels of possible cancer-causing chemicals in metformin diabetes medications are under investigation by the U.S. Food and Drug Administration.
Metformin is a prescription drug used to control high blood sugar in patients with type 2 diabetes.
Over the past year and a half, several typ...
FRIDAY, Dec. 6, 2019 (HealthDay News) -- The first generic versions of the multiple sclerosis drug Gilenya have been approved by the U.S. Food and Drug Administration.
The three generic versions of Gilenya (fingolimod) capsules were approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults.
Health News is provided as a service to Mountain Street Pharmacy site users by HealthDay. Mountain Street Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2019 HealthDay All Rights Reserved.